Rare diseases
Investigational molecules
Locations
Back to Hungary556 clinical trials in Debrecen, Hungary across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
HungaryA study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes
HungaryA Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment
HungaryA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
HungaryStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
HungaryStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
HungaryStudy of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
HungaryStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
HungaryStudy of Tibulizumab to Treat Adults with Hidradenitis Suppurativa
HungaryComparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery
HungaryStudy of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)
HungaryComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for plaque psoriasis and chronic urticaria. Multiple trials are investigating innovative therapies for both moderate to severe cases, including genital manifestations.
Focus on long-term safety and efficacy of new therapeutic agents for chronic skin conditions.
Leading research into heart failure prevention and cardiovascular disease management. Trials examining innovative treatments and preventive approaches for high-risk patients.
Emphasis on reducing major cardiovascular events and improving patient outcomes.
Groundbreaking research addressing obesity and type 2 diabetes. Studies evaluating combination therapies and novel approaches for weight management in diverse patient populations.
Investigation of treatments combining weight reduction with diabetes management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
